Omaxe SEBI ban: SAT stay order for investors in 2024

Sep 02, 2026•3 min read

Omaxe Ltd

OMAXE

Ask Iris

What the dispute is about

The Securities Appellate Tribunal (SAT) has intervened in the regulatory action taken by the Securities and Exchange Board of India (SEBI) against NCR-based real estate developer Omaxe Limited over alleged irregularities in its financial statements. SEBI’s order, dated July 30, 2024, barred Omaxe, its chairman Rohtas Goel, managing director Mohit Goel, and other entities and individuals from accessing the securities market for two years. The order also carried monetary penalties across multiple parties.

The matter has drawn attention because it involves market-access restrictions and alleged misrepresentation in financial reporting across three financial years. It also has practical implications for whether the company and key individuals can buy or sell securities, and whether individuals can hold key managerial roles in other listed entities.

SEBI’s July 30, 2024 order and who it covered

According to the information provided, SEBI alleged that Omaxe misrepresented its financial statements for financial years 2018-19, 2019-20 and 2020-21. The alleged misstatements were said to involve various line items, including revenue, debtors, advances and expenses.

SEBI’s action included a two-year restriction on accessing the securities market. It restrained six entities, including Omaxe, Rohtas Goel and Mohit Goel, from buying, selling, or otherwise dealing in securities, directly or indirectly, or associating with the securities market in any manner for two years. SEBI also barred four other individuals from the securities market and prohibited them from holding key managerial positions in any other listed entity for two years.

Penalties and payment timelines set by SEBI

The regulator imposed penalties totalling Rs 47 lakh on 16 entities, including the six entities that were barred from the market. The individual penalties ranged from Rs 1 lakh to Rs 7 lakh. The penalties were required to be paid within 45 days as per the SEBI order.

In normalized terms, the total penalty of Rs 47 lakh equals INR 0.47 crore, while individual penalties ranged from INR 0.01 crore to INR 0.07 crore.

What triggered the SEBI proceedings

The SEBI proceedings followed a complaint that alleged Omaxe engaged in fraudulent transactions and diverted or siphoned off funds. The complaint also alleged misrepresentation of financial statements and inflated turnover, among other accusations.

The regulatory action, as described, focused on the accuracy and presentation of the company’s financial statements over multiple years, and the alleged impact of those representations on the securities market.

SAT’s intervention and the conditional stay

After SEBI’s July 30, 2024 order, Omaxe and other affected parties moved SAT to challenge the ruling. SAT passed an interim ruling on October 1 staying certain directions in SEBI’s order, subject to conditions.

SAT’s order stated that the directions at paragraphs 41(1) and (2) would remain stayed, subject to deposit of the penalty amount by the appellant within four weeks. These paragraphs relate to the securities market ban and the prohibition on holding key managerial positions in any other listed company that SEBI imposed on individuals.

This means the ban and related restrictions did not take immediate effect during the stay period, provided the penalty deposit condition was met.

Clarifying conflicting reports on “dismissal” vs “stay”

The provided material contains statements indicating that SAT “dismissed” Omaxe’s appeal against SEBI’s order. It also contains detailed reporting that SAT granted a stay in October 2024, and explicitly notes that “contrary to recent reports” suggesting the action was upheld, SAT provided interim relief.

Based on the later, more specific account provided, SAT’s October 1 interim order stayed the operative restrictions tied to the market ban and key managerial prohibitions, subject to the penalty deposit condition. The information also states that the appeal process remained active and that hearings continued into 2026.

Next procedural steps highlighted in the SAT interim order

The interim order described a filing schedule: SEBI was allowed four weeks’ time to file a reply, and a rejoinder would be filed within four weeks thereafter. The text also mentions a next hearing date of December 16.

Separately, the material notes that the stay “essentially suspends the ban” while SAT reviews the merits of the appeal. It also states that if SEBI proves financial misrepresentation, the market ban would be upheld, reflecting the conditional nature of interim relief.

In another legal matter involving the company, the Delhi High Court upheld an arbitral award directing Omaxe Ltd. to refund ₹3.35 crore to two co-allottees of a commercial unit in Omaxe Novelty Mall at Lawrence Road, Amritsar. The court also imposed ₹2 lakh in costs, payable equally to the two co-allottees within two weeks.

The case details included: Omaxe Ltd. v. Mr. Joginder Singh Nijjar & Anr., Case Number: FAO(OS) (COMM) 236/2023 & CM APPL. 55402/2023, Citation: 2026 LLBiz HC(DEL) 834.

Key facts at a glance

Item	Details (as stated)
SEBI order date	July 30, 2024
SAT interim order date	October 1 (year stated in context as 2024)
Core allegation	Misrepresentation in financial statements (FY 2018-19, 2019-20, 2020-21)
Market access restriction	Two-year ban (stayed via SAT interim order, subject to conditions)
Total penalties	Rs 47 lakh (INR 0.47 crore) across 16 entities
Individual penalties	Rs 1 lakh to Rs 7 lakh (INR 0.01 crore to INR 0.07 crore)
Condition for stay	Deposit of penalty amount within four weeks
Next hearing mentioned	December 16

Market impact and why this matters

For listed companies, a SEBI order restricting market access can affect routine capital-market activities and the ability of leadership to participate in the securities market. In this case, the stated interim stay provided temporary relief by suspending the immediate operation of the ban and related managerial restrictions, as long as the penalty deposit requirement was met.

At the same time, the underlying case remains live. The allegations relate to financial reporting for three fiscal years and include references to revenue-related items, debtors, advances and expenses. With hearings continuing, investors typically track disclosures for procedural updates such as filings, next hearing dates, and whether interim conditions are complied with.

Conclusion

SEBI’s July 2024 order imposed a two-year securities market ban on Omaxe and certain individuals and levied total penalties of Rs 47 lakh across 16 entities over alleged financial misrepresentation. SAT’s October 1 interim order stayed key restrictive directions, subject to the appellant depositing the penalty amount within four weeks, and the appeal process continues with further hearings including a date cited as December 16.

Frequently Asked Questions

SEBI alleged Omaxe misrepresented its financial statements for FY 2018-19, 2019-20 and 2020-21 through items including revenue, debtors, advances and expenses.

SEBI barred Omaxe, chairman Rohtas Goel, managing director Mohit Goel and other entities from accessing the securities market for two years and restricted dealing in securities.

SEBI imposed penalties totalling Rs 47 lakh (INR 0.47 crore) on 16 entities, with individual penalties ranging from Rs 1 lakh to Rs 7 lakh (INR 0.01 crore to INR 0.07 crore).

SAT stayed the directions relating to the market ban and certain managerial prohibitions, subject to deposit of the penalty amount within four weeks, as per its October 1 interim order.

The Delhi High Court upheld an arbitral award directing Omaxe to refund ₹3.35 crore to two co-allottees and imposed ₹2 lakh in costs, payable equally within two weeks.